Management of the complications of external beam radiotherapy and brachytherapy

Current Urology Reports

Volumn 7, Issue 3, 2006, Pages 200-208

  Loeb, Stacy ^b   Nadler, Robert B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; BELLADONNA ALKALOID; CHOLINERGIC RECEPTOR BLOCKING AGENT; FENBUFEN; ISPAGULA; LANOLIN ALCOHOL; LOPERAMIDE; METHYLCELLULOSE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PHENAZOPYRIDINE; SPASMOLYTIC AGENT; SUCRALFATE; SULFADIAZINE SILVER; XIPAMIDE;

ANAMNESIS; BLADDER DISEASE; BLADDER DISTENSION; BRACHYTHERAPY; CYSTITIS; DIARRHEA; DRY SKIN; DYSURIA; ERYTHEMA; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; INCONTINENCE; PHYSICAL EXAMINATION; PROSTATE CANCER; REVIEW; SKIN BIOPSY; SKIN DISEASE; TENESMUS;

ACUTE DISEASE; BRACHYTHERAPY; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY; TIME FACTORS;

EID: 33750326366     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-006-0022-0     Document Type: Review

References (46)

1. Cooperberg MR, Lubeck DP, Meng MV, et al.: The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 2004, 22:2141-2149.
2. Sharkey J, Chovnick SD, Behar RJ, et al.: Evolution of techniques for ultrasound-guided palladium 103 brachytherapy in 950 patients with prostate cancer. Tech Urol 2000, 6:128-134.
3. Mate TP, Gottesman JE, Hatton J, et al.: High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report. Int J Radiat Oncol Biol Phys 1998, 41:525-533.
4. Slater JD, Rossi CJ Jr, Yonemoto LT, et al.: Proton therapy for prostate cancer: the initial Loma Linda University experience. Int J Radiat Oncol Biol Phys 2004, 59:348-352.
5. Zelefsky MJ, Moughan J, Owen J, et al.: Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer. Int J Radiat Oncol Biol Phys 2004, 59:1053-1061.
6. Kuban D, Pollack A, Huang E, et al.: Hazards of dose escalation in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2003, 57:1260-1268.
7. Woel R, Beard C, Chen MH, et al.: Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilization. Int J Radiat Oncol Biol Phys 2005, 62:392-396. This recent paper from the Harvard group discusses the frequency of patient-reported radiotherapy complications requiring medical intervention.
8. Ames CD, Gray M: Voiding dysfunction after radiation to the prostate for prostate cancer. J Wound Ostomy Continence Nurs 2000, 27:155-167. This clinically oriented paper presents many helpful suggestions for improving the care and quality of life for patients with urinary problems after prostate radiation.
9. Roach M 3rd: Reducing the toxicity associated with the use of radiotherapy in men with localized prostate cancer. Urol Clin North Am 2004, 31:353-366. This review, written by a radiation oncologist specializing in prostate cancer, describes many of the common complications associated with prostate radiotherapy.
10. Fung AY, Enke CA, Ayyangar KM, et al.: Prostate motion and isocenter adjustment from ultrasound-based localization during delivery of radiation therapy. Int J Radiat Oncol Biol Phys 2005, 61:984-992.
11. Jereczek-Fossa BA, Marsiglia HR, Orecchia R: Radiotherapy-related fatigue. Crit Rev Oncol Hematol 2002, 41:317-325.
12. Greenberg DB, Gray JL, Mannix CM, et al.: Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. J Pain Symptom Manage 1993, 8:196-200.
13. Turesson I, Bernefors R, Book M, et al.: Normal tissue response to low doses of radiotherapy assessed by molecular markers: a study of skin in patients treated for prostate cancer. Acta Oncol 2001, 40:941-951.
14. Merrick GS, Butler WM, Wallner KE, et al.: Brachytherapy-related dysuria. BJU Int 2005, 95:597-602.
15. Flam TA, Peyromaure M, Chauveinc L, et al.: Post-brachytherapy transurethral resection of the prostate in patients with localized prostate cancer. J Urol 2004, 172:108-111.
16. Kollmeier MA, Stock RG, Cesaretti J, Stone NN: Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy. J Urol 2005, 173:808-812.
17. Mullokandov E, Gejerman G: Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy. Int J Radiat Oncol Biol Phys 2004, 58:1063-1071.
18. Di Muzio N, Longobardi B, Losa A, et al.: Seed migration in prostate brachytherapy: a re-implant case report. Br J Radiol 2003, 76:913-915.
19. RTOG/EORTC Late Radiation Morbidity Scoring Schema, version 2.0. http://www.rtog.org/members/toxicity/late. html. National Institutes of Health 1999. This is the universal criteria used to describe the late complications associated with radiation therapy, and is available to the public online.
20. Flanigan RC, Patterson J, Mendiondo OA, et al.: Complications associated with preoperative radiation therapy and Iodine-125 brachytherapy for localized prostatic carcinoma. Urology 1983, 22:123-126.
21. Hemal AK, Praveen BV, Sankaranarayanan A, Vaidyanathan S: Control of persistent vesical bleeding due to radiation cystitis by intravesical application of 15 (S) 15-methyl prostaglandin F2-alpha. Indian J Cancer 1989, 26:99-101.
22. Miura M, Sasagawa I, Kubota Y, et al.: Effective hyperbaric oxygenation with prostaglandin E1 for radiation cystitis and colitis after pelvic radiotherapy. Int Urol Nephrol 1996, 28:643-647.
23. Chong KT, Hampson NB, Bostwick DG, et al.: Hyperbaric oxygen does not accelerate latent in vivo prostate cancer: implications for the treatment of radiation-induced haemorrhagic cystitis. BJU Int 2004, 94:1275-1278.
24. Chong KT, Hampson NB, Corman JM: Early hyperbaric oxygen therapy improves outcome for radiation-induced hemorrhagic cystitis. Urology 2005, 65:649-653.
25. Merrick GS, Butler WM, Tollenaar BG, et al.: The dosimetry of prostate brachytherapy-induced urethral strictures. Int J Radiat Oncol Biol Phys 2002, 52:461-468.
26. Talcott JA, Manola J, Clark JA, et al.: Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol 2003, 21:3979-3986. This prospective cohort study compares patient-reported GU, GI, and sexual function at 24 months following EBRT, brachytherapy, and radical prostatectomy.
27. Denton A, Forbes A, Andreyev J, Maher EJ: Non-surgical interventions for late radiation proctitis in patients who have received radical radiotherapy to the pelvis. Cochrane Database Syst Rev 2002, 1:CD003455.
28. Dearnaley DP, Khoo VS, Norman AR, et al.: Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 1999, 353:267-272.
29. Larson DW, Chrouser K, Young-Fadok T, Nelson H: Rectal complications after modern radiation for prostate cancer: a colorectal surgical challenge. J Gastrointest Surg 2005, 9:461-466.
30. Theodorescu D, Gillenwater JY, Koutrouvelis PG: Prostatourethral-rectal fistula after prostate brachytherapy. Cancer 2000, 89:2085-2091.
31. Shah SA, Cima RR, Benoit E, et al.: Rectal complications after prostate brachytherapy. Dis Colon Rectum 2004, 47:1487-1492.
32. Chrouser KL, Leibovich BC, Sweat SD, et al.: Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer. J Urol 2005, 173:1953-1957. A recent article targeted at urologists, discussing the evaluation and surgical management of rectourethral and other fistulas following prostate radiotherapy.
33. Chinn DM, Holland J, Crownover RL, Roach M 3rd: Potency following high-dose three-dimensional conformal radiotherapy and the impact of prior major urologic surgical procedures in patients treated for prostate cancer. Int J Radiat Oncol Biol Phys 1995, 33:15-22.
34. Potosky AL, Davis WW, Hoffman RM, et al.: Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 2004, 96:1358-1367.
35. Grills IS, Martinez AA, Hollander M, et al.: High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol 2004, 171:1098-1104.
36. Zelefsky MJ, Eid JF: Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer. Int J Radiat Oncol Biol Phys 1998, 40:129-133.
37. Zelefsky MJ, McKee AB, Lee H, Leibel SA: Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate. Urology 1999, 53:775-778.
38. McKenzie M, MacLennan I, Kostashuk E, Bainbridge T: Postirradiation sarcoma after external beam radiation therapy for localized adenocarcinoma of the prostate: report of three cases. Urology 1999, 53:1228.
39. Amendola BE, Amendola MA, McClatchey KD, Miller CH Jr: Radiation-associated sarcoma: a review of 23 patients with postradiation sarcoma over a 50-year period. Am J Clin Oncol 1989, 12:411-415.
40. Brenner DJ, Curtis RE, Hall EJ, Ron E: Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000, 88:398-406.
41. Johnstone PA, Powell CR, Riffenburgh R, et al.: Second primary malignancies in T1-3N0 prostate cancer patients treated with radiation therapy with 10-year follow-up. J Urol 1998, 159:946-949.
42. Movsas B, Hanlon AL, Pinover W, Hanks GE: Is there an increased risk of second primaries following prostate irradiation? Int J Radiat Oncol Biol Phys 1998, 41:251-255.
43. Lowe BA, Stamey TA: Endoscopic topical placement of formalin soaked pledgets to control localized hemorrhage due to radiation cystitis. J Urol 1997, 158:528-529.
44. Pyeritz RE, Droller MJ, Bender WL, Saral R: An approach to the control of massive hemorrhage in cyclophosphamide-induced cystitis by intravenous vasopressin: a case report. J Urol 1978, 120:253-254.
45. Lojanapiwat B, Sripralakrit S, Soonthornphan S, Wudhikarn S: Intravesical formalin instillation with a modified technique for controlling haemorrhage secondary to radiation cystitis. Asian J Surg 2002, 25:232-235.
46. Barry MJ, Fowler FJ Jr, O'Leary MP, et al.: The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992, 148:1549-1557; discussion 1564.